IMC Chicago’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.3M Sell
215,900
-3,800
-2% -$271K 0.01% 963
2025
Q4
$13.6M Buy
219,700
+16,200
+8% +$953K ﹤0.01% 1040
2025
Q3
$11.9M Buy
203,500
+55,500
+38% +$3.23M ﹤0.01% 1055
2025
Q2
$8.62M Buy
148,000
+4,200
+3% +$237K ﹤0.01% 1089
2025
Q1
$7.14M Sell
143,800
-48,200
-25% -$2.47M ﹤0.01% 1039
2024
Q4
$8.59M Buy
192,000
+35,400
+23% +$1.68M ﹤0.01% 981
2024
Q3
$7.53M Sell
156,600
-84,100
-35% -$4.05M ﹤0.01% 947
2024
Q2
$12.3M Sell
240,700
-10,100
-4% -$553K 0.01% 702
2024
Q1
$13.6M Buy
250,800
+117,500
+88% +$6.13M 0.01% 591
2023
Q4
$7.51M Buy
133,300
+57,300
+75% +$3.24M 0.01% 747
2023
Q3
$4.69M Buy
+76,000
New +$4.81M ﹤0.01% 755

Other funds holding NTR

IMC Chicago's NTR Position: Q1 2026 in Review

IMC Chicago increased its Nutrien (NTR) stake by 268% in Q1 2026, buying an estimated $6.16M and bringing the position to 118,609 shares worth $8.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1359.

IMC Chicago first reported a position in NTR in Q3 2023 and has held it in 5 quarters since. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • IMC Chicago held 118,609 shares of Nutrien worth $8.95M as of Q1 2026.
  • IMC Chicago bought 86,384 Nutrien shares in Q1 2026, an estimated $6.16M.
  • Nutrien made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #1359 holding.
  • IMC Chicago first reported a position in Nutrien in Q3 2023 and has held it in 5 quarters since.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.